MIMRYLO

Serial Number 98786114
688

Registration Progress

Application Filed
Oct 4, 2024
Under Examination
May 27, 2025
Approved for Publication
Apr 1, 2025
Published for Opposition
Apr 1, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Nov 27, 2025 136 days

Trademark Image

MIMRYLO

Basic Information

Serial Number
98786114
Filing Date
October 4, 2024
Published for Opposition
April 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
May 27, 2025
Application
Pending
Classes
005

Rights Holder

Takeda Pharmaceuticals U.S.A., Inc.

03
Address
500 Kendall Street
Cambridge, MA 02142

Ownership History

Takeda Pharmaceuticals U.S.A., Inc.

Original Applicant
03
Cambridge, MA

Takeda Pharmaceuticals U.S.A., Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
136 days remaining
NOA E-Mailed - SOU Required
Due Date
November 27, 2025
Extension Available
Until May 27, 2026

Application History

17 events
Date Code Type Description
May 27, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 23, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 23, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 20, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRT F NON-FINAL ACTION E-MAILED
Dec 20, 2024 CNRT R NON-FINAL ACTION WRITTEN
Dec 16, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...